BioMatrix Specialty Pharmacy Partners With The National Hemophilia Foundation And Audaire Health To Improve Care For Patients With Bleeding Disorders

Innovative Digital Platform Increases Transparency and Accountability for Patients and Providers     

WESTON, Fla., Dec. 3, 2018 /PRNewswire/ -- BioMatrix Specialty Pharmacy announced today participation in a pilot program with the National Hemophilia Foundation (NHF) and Audaire Health Inc (Audaire) focused on reducing administrative burden, increasing patient adherence, and lowering health care costs.  Pilot participants include a small group of select pharmacies and Hemophilia Treatment Centers (HTCs) who will utilize Audaire's innovative data tracking tool demonstrating how the system can reduce cost of care and improve outcomes. Andrew Berg, CEO at Audaire asserts, "We are thrilled to announce our partnership with NHF and BioMatrix. It's a pleasure to find two partners as dedicated to simplifying the patient experience as we are. Our goal was to find pharmacy partners who value transparency, accountability, and driving better patient outcomes. BioMatrix is most definitely that partner."

The Audaire Platform allows patients to instantly record infusions by utilizing their smart phone (at home or on the go) or a small electronic device kept in the home. The HIPAA-compliant system offers treatment reminders and passive logging capabilities that instantly transmit infusions to the patient's care team.  This "real time" reporting provides opportunities for early intervention, preventing unnecessary and costly emergency room visits and/or hospitalizations. The Audaire Platform is unique in comparison to other logging devices. The system provides a nearly passive data input solution designed to ease reporting burden for patients and pharmacy providers. By capturing multiple data points including prescription, dispensation, pharmacy/clinic touch points, reported bleeds and other medication administration information, the Audaire Platform provides more robust capabilities than current logging systems. "NHF believes that following prescribed treatments is a key to lowering costs and improving quality of life for people with bleeding disorders," said Val D. Bias, CEO of the National Hemophilia Foundation. "We hope this program can make a real difference in people's lives."

"BioMatrix has a history of leveraging unique digital health technology producing positive outcomes for patients and reducing healthcare costs," BioMatrix Chief Clinical Officer Marc Stranz shares. "This program demonstrates our commitment to providing the tools and support that make managing a chronic condition easier." Data from the pilot will be evaluated to identify the number of meaningful interventions resulting in cost reductions and or avoidance, changes in patient adherence and reporting rates, and improvements in assay and inventory management processes. The program is limited to patients on service with providers participating in the pilot. Initial findings will be shared at relevant industry symposia in 2019.  

About BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy offers comprehensive, nationwide specialty pharmacy services and digital health technology solutions for patients with chronic, difficult to treat conditions. Our growing family of companies unites leaders in the specialty pharmacy industry to improve health and empower patients to experience a higher quality of life. The current BioMatrix family of companies includes: BiologicTx, Decillion Healthcare, Elwyn Pharmacy Group, Factor Support Network, Matrix Health, and Medex BioCare.

About the National Hemophilia Foundation
Established in 1948, National Hemophilia Foundation (NHF) is a national nonprofit patient advocacy organization dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research.  NHF is a leader in supporting innovative solutions to help people with bleeding disorders and their families manage their disorder and improve their quality of life.

About Audaire Health
Audaire Health Inc (Audaire) is a healthcare technology company that focuses on facilitating transparency and accountability between payer, provider, pharmacy and patient. On the front end, Audaire's patent pending platform allows patients to seamlessly log medication adherence and exacerbations in real time. On the back end, all stakeholders (payers, providers, pharmacies) have real time insight into patient behavior, physician behavior and pharmacy dispensations. The end result is more informed providers, better performing pharmacies, and better patient outcomes. 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomatrix-specialty-pharmacy-partners-with-the-national-hemophilia-foundation-and-audaire-health-to-improve-care-for-patients-with-bleeding-disorders-300758381.html

SOURCE BioMatrix Specialty Pharmacy